Skip to main content
Clinical Trials/ChiCTR2100052451
ChiCTR2100052451Not yet recruitingNot Applicable

发热型淋巴瘤预后因素的临床研究

复旦大学附属华东医院1 site in 1 country200 target enrollmentStarted: January 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
无进展生存期

Study Overview

Brief Summary

探索并建立发热型淋巴瘤预后积分系统,以期为临床上根据疾病预后不同而进行分层治疗提供依据,在循证医学基础上的个体化治疗将可延长患者的生存时间,改善疾病预后。

Study Design

Study Type
观察性研究
Primary Purpose
析因分组(即根据危险因素或暴露因素分组)
Masking
N/a

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 淋巴瘤定义诊断需符合 WHO 2016 年淋巴造血组织肿瘤分类标准。所有患者均有组织病理确诊。

Exclusion Criteria

  • Not provided

Arms & Interventions

发热型淋巴瘤组 vs 非发热型淋巴瘤组

Outcomes

Primary Outcomes

无进展生存期

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
复旦大学附属华东医院

Study Sites (1)

Loading locations...

Similar Trials

请与我们联系上传伦理审批文件。 发热型淋巴瘤预后因素的临床研究 | Clinical Trial